A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study to find out whether telehealth music therapy is a practical treatment for cognitive difficulties in blood cancer survivors. The researchers will also study whether music therapy and music education help improve cognitive function and other common symptoms such as anxiety, depression, and/or tiredness.
Eligibility criteria
Qualifiers
English-proficient, aged 18 or older
Diagnosis of lymphoma, leukemia, or myeloma
Stable oncologic disease or no evidence of disease as indicated in the medical chart or by the oncology team
Score of <54 on the FACT-Cog PCI subscale
Disqualifiers
Less than 3 months since completion of surgery, radiation, induction chemotherapy (for newly diagnosed or relapsed disease), transplantation, or immunotherapy (e.g., CAR T-Cell, bispecific antibodies)
If there is a defined treatment period, the patient must be at least 3 months from treatment completion
If the patient is on continuous therapy, patient must have completed at least 6 months of the therapy
Maintenance therapies are allowed
Trial design
Treatments tested in this trial
- Music Therapy/MT
- Therapist-Attention Music Education/TAME Control
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov